Navigation Links
BioLife Solutions Joins Prestigious Biomedical Excellence for Safer Transfusion Collaborative
Date:12/29/2008

BOTHELL, Wash., Dec. 29 /PRNewswire-FirstCall/ -- BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer and marketer of proprietary cGMP hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced that it has joined the Biomedical Excellence for Safer Transfusion (BEST) Collaborative, an international consortium of leading scientific, clinical, and commercial partners whose mission is to explore collaborative ways to improve transfusion-related services through standardization of analytic techniques, development of new procedures and execution of clinical trials in hemotherapy.

Zbigniew "Ziggy" M. Szczepiorkowski, MD, PhD, co-chair of the BEST cellular therapy team and Associate Professor of Pathology and of Medicine at Dartmouth Medical School, commented on the addition of BioLife Solutions as a new corporate member of BEST by stating, "We're very pleased to welcome BioLife to the BEST Collaborative. BioLife joins other corporate members in the quest to advance the field of transfusion medicine and to work with world leading experts. Results from recent initial safety studies conducted by BioLife and submission of FDA Master Files understandably elevates the profile of the company in the field of transfusion medicine in the US and internationally. We look forward to mutually beneficial scientific collaboration with BioLife and other BEST corporate members to identify ways to extend the shelf-life and improve the transportation logistics as well as post-preservation viability and functional yield of transfusion-related source material and derived cell-based clinical products."

Mike Rice, BioLife's chairman and CEO, noted "Since its formation, the scientific members of BEST have collectively published over 50 peer reviewed scientific articles related to efforts to continually improve quality, safety and efficiency in transfusion medicine. W
'/>"/>

SOURCE BioLife Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. BioLife Solutions Completes Safety Studies on HypoThermosol(R) and CryoStor(TM)
2. BioLife Solutions Granted European Biopreservation Patent
3. BioLife Solutions Submits FDA Master File on HypoThermosol(R) Preservation and Storage Media for Cells, Tissues
4. BioLife Solutions HypoThermosol(R) Adopted by MicroIslet for Processing Pancreatic Islet Cells to Treat Diabetes
5. BioLife Solutions Credit Facility Increased to $9 Million
6. BioLife Solutions Announces FDA Master File Acceptance for CryoStor(TM) Pre-formulated Cryopreservation Media
7. BioLife Solutions Outsourcing Manufacturing, Warehousing, and Order Fulfillment to Bioserv Corporation
8. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
9. BioLife Solutions Expands Scientific Advisory Board
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. DuPont Acquires Ag Data Management Business to Enhance Information Solutions for Growers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...wswire/ -- Biopharmaceutical company Kiadis,Pharma... enrolled in its,multinational registration clinic...how reduction in transplant related mortality (TRM... transplantation with a mismatched,(haplo-identica...allogeneic,stem cell transplantation but without h...
(Date:11/30/2009)...e-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasd... Administration (FDA) has granted orphan drug desi...ridine phosphate, for the rare autoimmune disease ... has previously received orphan drug designation i...or Medicinal Products for Human Use of the Europea...
(Date:11/30/2009)...swire-Asia/ -- WuXi PharmaTech (NYSE: WX ), a,le...evice research and,development outsourcing company...nnounced that it had been selected to the Deloitte...consecutive year. The list recognizes the 50,faste... and telecommunications,industries based on revenu...
(Date:11/28/2009)...l Advisory Committee on Climate Change (NACCC) thr...ct in collaboration with the Vanuatu Meteorologica...e generated preliminary climate change and sea lev...the country’s SNC reporting to the United Na...CC). , Port Vila, Vanuat...
Breaking Biology Technology:Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4
...n Investment to Finance Growth in Chindex,s Health...ina, BETHESDA, Md., Nov. 7 /Xinhua-PRNewswire/ --...ding independent American provider of Western,heal...lic of China, today,announced that it has agreed t... Management group. The investment will consist of ...
...., Nov. 7 Transgenomic Inc. (OTC,Bulletin Board: ...Transgenomic Inc. Third Quarter 2007 Earnings Rele...ay, November 7, 2007 @ 5:00 p.m. Eastern, Where: ... How: Live over the Internet -- Simply log on...tact: Investor Relations -- 402-452-5400 To acce...
... CA, Nov. 7 /PRNewswire-FirstCall/ - Nventa,Biopha...y financial results,for the third quarter ended Se...herwise, are in Canadian dollars. Nventa reported...r the,three months ended September 30, 2007, compa...are, for the same period in 2006. For the nine,mon...
Other Biology Technology:JPMorgan's Principal Investment Management Group to Invest in Chindex International, Inc. 2JPMorgan's Principal Investment Management Group to Invest in Chindex International, Inc. 3Webcast Alert: Transgenomic Inc. Announces Third Quarter 2007 Earnings Release Conference Call Webcast 2Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 2Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 3Nventa Biopharmaceuticals Corporation announces third-quarter 2007 financial results 4
(Date:11/30/2009)...port published in the December 2009 print issue of...r type of control over their fertility that women ...s have found how and where androgenic hormones wor... and male fertility. This opens a promising avenue...scovery also offers hope to those who cannot have ...
(Date:11/26/2009)... are some of the Ocean,s most distinctive resident...s strange head shape, says Michelle McComb from F... the shark,s vision. ,Perhaps their visual field h...McComb, giving the sharks excellent stereovision a... there were two schools of thought on this theory....
(Date:11/26/2009)...out in eight European countries has shown that clo... pandemic could have a significant role in reducin... open access journal BMC Infectious Diseases com...nd weekends/holidays, finding that they were reduc...elt and Antwerp University, Belgium, led a team of...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2School closure could reduce swine flu transmission by 21 percent 2New stem cell identification technology could cure breast cancer 4969 1New stem cell identification technology could cure breast cancer 4969 2First results from major European patient survey show devastating impact of living with breakthrough cancer pain 56899 1First results from major European patient survey show devastating impact of living with breakthrough cancer pain 56899 2ThromboGenics is Shortlisted for 22Biotech Company of the Year 22 and 22Licensing Deal of the Year 22 at Scrip Awards 2009 13998 1ThromboGenics is Shortlisted for 22Biotech Company of the Year 22 and 22Licensing Deal of the Year 22 at Scrip Awards 2009 13998 2ThromboGenics is Shortlisted for 22Biotech Company of the Year 22 and 22Licensing Deal of the Year 22 at Scrip Awards 2009 13998 3
...eir kind, researchers at Rice University and The U...ve determined that carbon nanotubes injected direc...ause no immediate adverse health effects and circu...d by the liver. , The findings are from the first ...on nanotubes, a revolutionary nanomaterial that ma...
...scoveries are named Charlotte, but they are weavin...studies at Texas A&M University have led to th... one species found for the first time in Texas. , ...dation, Henderson, who is earning a master,s degre...ribution and abundance in the 515-acre Lick Creek ...
... of Warwick should have gardeners and commercial g...ic waste composts. The University,s plant research... paper based composts are proving to be a major we...s. , A University of Warwick research team under ...use of composts can reduce the incidence of some i...
Other Biology News:Pure carbon nanotubes pass first in vivo test 2Ground spider diversity studied in research project 2Recycled paper and compost could both be key tools to control plant disease 2
...dom EVO96R and Freedom EVO384R are fast multi-chan...t, available in three different sizes, with a mult... deliver significant time saving, with true parall...f your assays with the Freedom EVOware program. ...
Bovine Serum, Sterile Filtered from Meridian Life Science, Inc.
Bromophenol Blue sodium salt from Sigma-Aldrich
Blue Magnet from StemCell Technologies, Inc.
Biology Products: